Brain’s support cells drive neurodegeneration too
When it comes to diseases like Alzheimer’s and Parkinson’s, attention typically focuses on neurons dying. But the brain’s most abundant cell type, astrocytes, may be just as central to the problem, and potentially to the solution.
Astrocytes are the dominant cell type in the brain. They provide metabolic support to neurons, regulate brain chemistry, maintain the blood-brain barrier, and help clear waste. But in the aging brain, their behavior shifts. They begin producing more signals that promote inflammation, and this shift is increasingly recognized as a driver of neurodegeneration. The researchers outline how this behavioral change contributes to tissue deterioration in neurodegenerative disease and why it may be possible to reverse it.
What makes this significant is the implication that astrocyte behavior is not fixed. These cells respond to signals in their environment. Change those signals, and the cells can change too. That makes them a potential therapeutic target, not just a bystander in disease progression. Strategies aimed at returning astrocytes to a less inflammatory state are now drawing serious attention in the field.
Inflammaging in the brain
The link between astrocytes and inflammation fits a broader pattern in aging biology. Chronic low-grade inflammation in aged tissue, a process known as inflammaging, is one of the central mechanisms underlying age-related disease. In the brain, both microglia and astrocytes contribute to this inflammatory environment. While microglia have received more attention in recent years, the growing focus on astrocytes broadens the picture of how brain inflammation develops and persists in older adults.
Toward therapeutic strategies
No specific therapies targeting astrocyte behavior have reached the clinic yet. But mechanistic understanding is advancing. Researchers are investigating small molecules and biological agents that might block the transition of astrocytes into a pro-inflammatory state, often called reactive astrogliosis. Reducing other sources of inflammation in the aging body may also indirectly shift astrocyte behavior. The key takeaway is that neurodegeneration is not simply a matter of neurons dying. It reflects a breakdown across an entire cellular ecosystem, one that includes the supporting cells long considered secondary.